Načítá se...

Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chen, Yaoyu, Peng, Cong, Sullivan, Con, Li, Dongguang, Li, Shaoguang
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/
https://ncbi.nlm.nih.gov/pubmed/20184539
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!